background
virus
oblig
parasit
depend
cellular
machineri
host
regener
manufactur
protein
antivir
drug
market
today
target
viral
protein
howev
recent
strategi
involv
target
host
cell
protein
pathway
mediat
viral
replic
new
approach
would
effect
virus
minim
drug
resist
toxic
method
cytomegaloviru
replic
latenc
immun
respons
mediat
intermedi
earli
protein
main
protein
determin
effect
drug
cytomegaloviru
inhibit
review
explain
intermedi
earli
protein
modifi
action
cyclosporin
immunosuppress
antivir
drug
also
link
pathway
mediat
cyclosporin
cytomegaloviru
replic
encod
protein
result
intermedi
earli
protein
influenc
cellular
cyclophilin
pathway
affect
cyclosporin
mediat
viral
replic
anticytomegaloviru
drug
conclus
cyclosporin
dual
function
cytomegaloviru
pathogenesi
immunosuppress
effect
establish
viru
replic
inhibit
tcell
function
also
anticytomegaloviru
effect
mediat
intermedi
earli
protein
function
involv
cyclophilin
pathway
virus
without
replic
machineri
depend
host
cell
prolifer
virus
interact
host
cell
activ
enzym
cofactor
requir
replic
respons
host
cell
thu
reflect
pathogen
properti
viru
treatment
viral
diseas
drug
primarili
target
special
viral
protein
current
antivir
drug
includ
nucleotid
analog
neuraminidas
enzym
channel
revers
transcriptas
proteas
inhibitor
chemokin
receptor
antagonist
mani
drug
target
viral
protein
fraught
cytotox
tend
caus
drug
resist
although
drug
target
cellular
factor
pathway
advantag
overcom
cellular
barrier
toxic
compromis
use
reason
need
discov
altern
antivir
compound
minim
side
effect
immunosuppress
patient
undergo
organ
transplant
suscept
cytomegaloviru
cmv
infect
could
caus
reject
interestingli
two
immunosuppress
drug
mycophenol
acid
mizoribin
better
anticmv
activ
ganciclovir
allow
good
graft
surviv
immunosuppress
drug
develop
target
specif
protein
kinas
essenti
viru
replic
among
artesun
drug
inhibit
cellular
kinas
signal
nfjb
protein
sirolimu
everolimu
rapamycin
inhibitor
target
cellular
signal
drug
shown
activ
ganciclovirand
foscarnetresist
cmv
strain
review
discuss
associ
cellular
pathway
mediat
cmv
cyclosporin
csa
demonstr
csa
use
immunosuppress
drug
organ
transplant
anticmv
agent
cmv
dna
viru
herpesvirida
famili
highli
speciesspecif
human
cytomegaloviru
hcmv
studi
anim
result
develop
mani
anim
model
viru
seropreval
studi
shown
popul
seroposit
cmv
immun
system
easili
control
viru
caus
activ
infect
facilit
lifelong
latenc
immunosuppress
transplant
recipi
hiv
patient
foetu
risk
acquir
cmv
infect
high
risk
infect
solid
organ
transplant
sot
recipi
associ
serostatu
donor
recipi
type
transplant
organ
host
immun
statu
viral
factor
organ
tissu
transplant
cmv
infect
mostli
report
seroposit
cmvseroneg
r
recipi
rather
drrecipi
also
shown
hematopoiet
cell
transplant
greatest
risk
infect
donor
cmv
seroneg
recipi
seroposit
pregnant
women
among
factor
increas
risk
cmv
infect
socioeconom
statu
parasit
infect
cmv
viral
load
serostatu
age
noncaucasian
educ
level
close
contact
young
children
preval
cmv
infect
babi
born
mother
primari
cmv
infect
show
neurolog
diseas
birth
make
preval
cmvrelat
disabl
higher
childhood
diseas
risk
vertic
transmiss
cmv
higher
primari
nonprimari
cmv
infect
infect
symptomat
congenit
cmv
infect
may
also
develop
primari
infect
occur
seroposit
women
seroneg
women
usa
congenit
infect
acquir
nonprimari
cmv
infect
primari
infect
thu
congenit
infect
acquir
nonprimari
cmv
infect
compar
primari
infect
usa
regard
cmv
diseas
outcom
evid
symptomat
outcom
primari
nonprimari
cmv
infect
differ
greatest
risk
cmv
infect
period
fetal
organogenesi
first
earli
second
trimest
vertic
transmiss
mostli
occur
third
trimest
fetus
mostli
born
healthi
seem
differ
symptom
among
babi
born
pregnanc
affect
primari
nonprimari
cmv
infect
mortal
symptomat
congenit
infect
children
result
liver
dysfunct
coagul
disord
secondari
bacteri
infect
complic
cmv
congenit
infect
includ
central
nerv
system
cn
diseas
meningoenceph
calcif
microcephali
disrupt
neuron
migrat
germin
matrix
cyst
ventriculomegali
cellular
hyperplasia
lethargi
hypotonia
seizur
chorioretin
complic
sever
cmv
infect
occur
earli
stage
pregnanc
newborn
postnat
cmv
infect
caus
hepat
neutropenia
thrombocytopenia
prematur
low
birth
weight
sensorineur
hear
loss
snhl
due
viru
replic
inner
ear
report
young
kid
disord
develop
earli
birth
symptomat
asymptomat
neonat
later
childhood
children
approxim
infant
congenit
infect
may
manifest
sever
symptomat
cytomegal
inclus
diseas
cid
cytomegal
inclus
bodi
diseas
cibd
infant
cid
develop
cmv
neurolog
diseas
cmv
reach
brain
foetus
brain
cmv
infect
associ
viral
replic
endotheli
cell
bloodbrain
barrier
bbb
process
facilit
viruscross
brain
parenchyma
access
astrocyt
anoth
way
viru
enter
brain
infect
ependym
cell
choroid
plexu
lead
dissemin
viru
cerebrospin
fluid
subsequ
infect
brain
parenchyma
viru
establish
latent
infect
myeloid
cell
eventu
infiltr
brain
develop
microglia
cell
destruct
injuri
bbb
endotheli
cell
result
extravas
monocyt
facilit
brain
infect
nervou
tissu
cmv
induc
injuri
interf
cell
differenti
morphogenesi
surviv
control
apoptosi
mechan
infect
neural
stem
cell
interf
brain
development
process
impact
cmv
replic
endovascular
system
viral
replic
interfer
brain
develop
migrat
neocort
neuron
cortic
plate
caus
disabl
cyclophilin
cyclophilin
cyp
group
highli
conserv
cellular
protein
found
ubiquit
anim
plant
tissu
protein
uniqu
chemic
structur
consist
amino
acid
amino
acid
contain
variat
interact
domain
among
protein
variou
locat
differ
function
least
cyp
identifi
although
differ
distribut
tissu
organ
local
structur
similar
peptidylprolyl
isomeras
ppias
activ
human
seven
cyp
kda
identifi
hcypa
hcypb
hcypc
hcypd
hcype
hcypnk
cellular
function
cyp
observ
protein
fold
traffick
cyclophilin
cypa
bind
cyclosporin
csa
first
isol
bovin
thymocyt
cypa
resembl
high
abund
cyp
eukaryot
cell
concentr
rang
total
cellular
protein
cypa
encod
gene
chromosom
consist
amino
acid
molecular
weight
dalton
human
cypa
compos
eight
antiparallel
bbarrel
structur
enclos
two
ahelic
locat
hydrophob
core
cypa
contain
one
hydrophob
seven
aromat
residu
within
drum
molecul
csabind
area
csabind
site
compos
loop
region
four
bstrand
posit
cypa
play
import
role
variou
cellular
function
includ
inflamm
apoptosi
protein
stimul
immun
respons
produc
inflammatori
cell
endotheli
cell
monocyt
vascular
smooth
muscl
cell
platelet
extracellular
cypa
interact
cell
membran
heparin
receptor
also
function
chemoattract
monocyt
neutrophil
eosinophil
lymphocyt
like
cyp
cypa
act
chaperon
regul
cellular
protein
receptor
express
activ
protein
also
involv
sever
signal
pathway
signal
transduct
pathway
uniqu
lymphocyt
cellspecif
tyrosin
kinas
itk
brain
cypa
mostli
local
neuron
play
role
neuron
differenti
embryo
growth
adult
cortic
plastic
cypa
maintain
integr
function
bbb
protect
neuron
traumat
brain
injuri
block
bbb
permeabl
effect
ischemia
oxid
stress
brain
injuri
cypa
induc
endotheli
cell
prolifer
migrat
well
recruit
monocyt
repair
brain
blood
vessel
moreov
cypa
induc
extracellular
signalregul
kinas
erk
protein
kinas
b
pkb
akt
signal
bind
cell
surfac
receptor
bind
stimul
express
antiapoptot
protein
mediat
neurogenesi
brain
protect
repair
cyclosporin
cyclosporin
csa
acid
cyclic
peptid
figur
extract
fungu
tolypocladium
inflatum
gam
immunosuppress
drug
primarili
use
organ
transplant
drug
also
use
treatment
renal
neurodegen
autoimmun
diseas
recommend
treatment
rheumatoid
arthriti
psoriasi
atop
dermat
endogen
uveiti
immunosuppress
activ
csa
result
format
csacypa
complex
high
affin
calcineurin
cellular
phosphatas
mediat
tcell
activ
csacypa
complex
locat
interfac
calcineurin
catalyt
regulatori
subunit
control
phosphatas
activ
biolog
function
csa
also
affect
express
nfjb
modul
antigenspecif
immun
ca
independ
respons
block
jnk
mapk
signal
pathway
howev
use
csa
treatment
diseas
advers
effect
caus
abnorm
glomerular
filtrat
nephrotox
neurotox
hepatox
cardiovascular
disord
calcineurin
factor
includ
endothelin
csa
cell
induc
inflamm
apoptosi
mediat
jnk
mapk
activ
cell
receptor
erk
transcript
factor
control
cellular
process
includ
differenti
prolifer
apoptosi
activ
jnk
mapk
also
requir
involv
csasensit
protein
kinas
major
mitogenactiv
protein
kinas
mapk
mapk
kinas
mapkk
mapkk
kinas
mapkkk
requir
activ
mediat
jnk
pathway
modul
nfjb
activ
jnk
pathway
signal
nfjb
activ
csa
control
csa
mediat
jnk
signal
pathway
member
rho
subfamili
small
gprotein
especi
guanin
nucleotid
exchang
factor
control
express
immunosuppress
agent
tacrolimu
calcineurin
nfat
pathway
inhibitor
use
mechan
block
jnk
pathway
subsequ
tcell
activ
similarli
immunosuppress
activ
csa
mediat
calcineurin
block
jnk
activ
unlik
immunosuppress
agent
calcineurin
control
jnk
complex
pkcu
csa
deriv
sever
csa
deriv
figur
interact
well
virus
caus
seriou
side
effect
among
deriv
alisporivir
figur
nonimmunosuppress
analog
csa
synthes
contain
sarcosin
instead
dmethylalanin
posit
ppias
domain
methylleucin
instead
ethylvalin
posit
calcineurin
domain
modif
alter
ppias
activ
calcineurinbind
abil
deriv
howev
alisporivir
still
result
side
effect
includ
revers
hyperbilirubinemia
pancreat
use
combin
ribavirin
treat
hepat
c
viru
hcv
infect
figur
b
anoth
nonimmunosuppress
analog
csa
similar
structur
parent
molecul
one
modif
methylleucin
posit
replac
methylisoleucin
deriv
antivir
effect
exhibit
pharmacokinet
profil
csa
without
nephrotox
figur
c
synthes
csa
deriv
inhibit
hcv
infect
without
detect
inhibit
calcineurin
phosphatas
treatment
drug
associ
transient
increas
interferon
cytokin
respons
clearanc
virus
anoth
deriv
csa
metabol
stabl
favor
pharmacokinet
allow
less
frequent
low
therapeut
dose
drug
also
effect
bilirubin
transport
without
affect
major
protein
drug
metabol
sanglifehrin
sfa
figur
new
immunosuppress
agent
isol
streptomyc
strain
protein
interact
strongli
cypa
calcineurin
phosphatas
also
potent
inhibitor
mitochondri
permeabl
transit
heart
reperfus
injuri
cypa
essenti
protein
hcv
hepat
b
viru
hbv
replic
hcv
cypa
interact
sever
viral
protein
includ
serin
proteas
viral
rnadepend
rna
polymeras
cystein
proteas
interact
cypa
stimul
viral
genom
replic
virion
morphogenesi
viral
particl
assembl
domain
replic
virus
also
mediat
protein
includ
tcell
intracellular
antigen
bind
termin
stemloop
flaviviru
genom
facilit
synthesi
minusstrand
rna
csa
block
interact
indirectli
inhibit
genom
rna
amplif
inhibitori
effect
csa
deriv
hbv
associ
distribut
mitochondri
transit
pore
calcium
signal
cypa
form
complex
csa
import
viru
entri
trigger
express
hbv
surfac
antigen
hbsag
mediat
viru
dna
replic
envelop
protein
secret
format
csacypa
complex
inhibit
hcv
hbv
sodium
taurochol
cotransport
polypeptid
receptor
cypa
also
mediat
influenza
viru
replic
associ
viru
core
influenza
virus
cypa
interact
protein
result
interfer
viru
nuclear
transloc
prevent
posttranscript
viral
genom
inhibit
influenza
viru
replic
csa
nonimmunosuppress
deriv
involv
cypadepend
independ
pathway
cypaindepend
inhibit
occur
rna
polymeras
ii
inhibit
viru
replic
also
achiev
nonimmunosuppress
analog
csa
human
immunodefici
viru
hiv
rna
viru
caus
acquir
immunodefici
syndrom
aid
viral
capsid
undergo
morpholog
chang
target
cell
cytosol
mediat
cell
factor
form
fusion
complex
trimcyp
block
viru
replic
postentri
step
trimcyp
interact
retroviru
capsid
caus
capsid
disassembl
inhibit
viru
infect
ca
protein
capsid
surfac
facilit
interact
cellular
cypa
infect
control
viru
replic
cypa
also
interact
gag
polyprotein
mediat
viru
fusion
entri
uncoat
viral
genom
integr
host
dna
modul
immun
respons
csa
analog
interact
cypa
disrupt
cypabind
loop
locat
ntermin
ca
protein
inhibit
infect
certain
cell
type
sever
acut
respiratori
syndrom
sar
viru
cypa
bind
sarscov
n
protein
mediat
viral
rna
synthesi
coronavirus
cypa
also
interact
nonstructur
viral
protein
cell
signal
cmv
cmv
cellular
entri
replic
involv
sever
factor
includ
epiderm
growth
factor
receptor
egfr
integrin
plateletderiv
growth
factor
receptora
pdgfra
bind
receptor
initi
ca
homeostasi
activ
phospholipas
c
releas
arachidon
acid
metabolit
diacylglycerol
activ
protein
kinas
c
inositol
triphosph
induc
calcium
influx
viru
also
bind
integrin
anoth
receptor
mediat
actin
depolymer
facilit
viru
transloc
nucleu
activ
src
pathway
alter
cytoskeleton
arrang
also
associ
activ
integrin
egfr
receptor
reduc
activ
rhoa
gtpase
viru
activ
extracellular
signalregul
kinas
erk
also
known
mapk
pathway
interact
occur
kinas
import
viral
replic
hcmv
replic
requir
nfjb
activ
major
immedi
earli
promot
miep
respons
transcript
gene
cell
nfjb
specif
promot
protein
activ
hcmv
either
independ
synergist
miep
special
site
cell
transcript
factor
either
stimul
repress
transcript
nfjb
crebatf
ying
repressor
factor
erf
repress
transcript
occur
factor
includ
involv
posttransl
modif
histon
tnf
hcmvpermiss
cell
miep
associ
acetyl
histon
peripher
blood
monocyt
miep
associ
heterochromatin
protein
chromosom
protein
implic
gene
silenc
hcmv
remain
latent
monocyt
serv
carrier
viru
although
mechan
reactiv
hcmv
still
known
suggest
host
complex
facilit
chromatin
transcript
fact
bind
miep
inhibit
complex
inhibit
viru
activ
hcmv
alter
express
cell
cycl
regulatori
protein
cyclindepend
kinas
infect
cell
arrest
phase
cell
cycl
macromolecul
need
cell
growth
viru
replic
synthes
hcmv
transactiv
promot
induc
accumul
howev
hcmv
repress
transactiv
activ
outcom
interact
includ
stimul
dna
synthesi
cell
cycl
arrest
inhibit
apoptosi
viru
also
respond
alter
cell
growth
activ
host
gene
interact
histon
deacetylas
hdac
retinoblastoma
rb
tumor
suppressor
protein
via
lxcxedepend
pathway
bind
rb
protein
transcript
factor
partial
control
cell
growth
hcmvinfect
cell
pocket
protein
cell
growth
arrest
occur
rb
protein
repress
transcript
activ
transcript
factor
bind
transcript
factor
caus
releas
activ
ecdk
kinas
allow
cell
cycl
progress
g
phase
hcmv
increas
express
tumor
suppressor
factor
infect
cell
hcmv
bind
although
hcmv
block
function
hcmv
inhibit
apoptosi
pathway
sever
strategi
hcmv
stimul
antiapoptot
signal
pathway
delay
onset
activ
also
cmv
gene
viral
inhibitor
apoptosi
vica
gene
encod
viral
mitochondrialoc
inhibitor
apoptosi
vmia
affect
permeabil
mitochondri
outer
membran
prevent
releas
cytochrom
c
necessari
activ
proapoptot
pathway
adapt
surviv
viru
host
cell
enhanc
major
tegument
protein
protein
protein
bind
cyclin
caus
cyclin
phosphoryl
avoid
cdkmediat
inhibit
viral
replic
cmv
contain
gene
encod
cxc
chemokin
viru
use
cytokin
activ
preferenti
attract
neutrophil
serv
viru
carrier
viru
also
possess
ul
gene
induc
express
hcmv
genom
contain
gproteincoupl
receptor
gpcr
gpcr
prevent
leukocyt
recogn
hcmvinfect
cell
block
effect
leukocyt
neighbour
cell
best
character
among
gpcr
stimul
migrat
hcmvinfect
cell
vascular
injuri
site
lead
atherosclerosi
restenosi
host
cell
infect
hcmv
express
type
interferon
ifn
ifnstimul
gene
proinflammatori
cytokin
compon
innat
cellular
respons
requir
transcript
activ
interferon
regulatori
factor
defenc
mechan
hcmv
inhibit
product
ifn
block
ifnastimul
respons
disrupt
ifna
signal
transduct
pathway
decreas
express
multipl
ifnrespons
gene
hcmv
particularli
late
infect
stage
also
inhibit
nfjb
signal
respons
product
proinflammatori
cytokin
tnfa
cyclosporin
cypa
cmv
csa
immunosuppress
agent
potenti
cmv
infect
immunosuppress
activ
csa
via
csacypa
interact
calcineurin
cellular
pathway
mediat
cypa
sensit
csa
cellular
pathway
fulli
control
cmv
viral
infect
replic
addit
share
signal
nfjb
mapk
jnk
involv
cypa
activ
replic
cmv
demonstr
mous
model
silenc
cypa
mrna
fact
cypa
requir
hcmv
lytic
infect
latenc
establish
reactiv
also
regul
ie
protein
lytic
gene
express
hcmv
replic
cycl
util
cypa
may
deplet
concentr
organ
compromis
cellular
protein
fold
differenti
function
nervou
tissu
affect
infect
may
caus
cnsassoci
abnorm
phenomena
suggest
cypa
could
potenti
therapeut
target
treatment
hcmv
infect
although
csa
common
immunosuppress
drug
use
organ
transplant
mediat
hcmv
reactiv
vivo
csacypa
complex
respons
may
result
overal
immunosuppress
cmv
enter
cell
stimul
secret
type
ifn
well
proinflammatori
cytokin
cypa
nfjb
transcript
critic
cmv
treatment
respons
control
cmv
protein
immun
respons
cmv
carri
tolllik
stimul
glycoprotein
evid
previou
studi
suggest
oper
legend
cypa
upregul
cmv
infect
involv
inflamm
similar
cmv
interact
establish
cmv
ectodomain
cmv
enter
cell
stimul
cypa
product
interact
mediat
viru
replic
earli
immun
respons
gene
signal
block
cmv
reinfect
addit
activ
nfjb
pathway
import
monocyt
macrophag
modul
cellular
microenviron
necessari
approv
cmv
previous
cmv
success
downregul
encod
encod
us
microrna
necessari
cellular
modul
downregul
special
code
area
utr
sequenc
lead
reduc
activ
ifnrel
gene
nfjb
tnfa
induc
inhibit
immun
respons
mediat
inhibit
also
mediat
csa
block
cypa
function
subsequ
interact
mani
virus
success
replic
induc
oxid
stress
cypa
import
mediat
replic
xiao
et
al
studi
demonstr
cmv
infect
induc
substanti
level
oxid
stress
oxid
stress
stimul
cypa
product
cypa
play
role
activ
pathway
pathway
necessari
activ
nfjb
transcript
factor
creb
chop
max
mediat
viral
cellular
gene
express
enhanc
viru
replic
silenc
cypa
inhibit
viru
gene
express
csa
affect
express
cypa
activ
cypa
express
csa
cypa
target
drug
inhibit
cypamedi
mapk
pathway
addit
antioxid
compound
also
control
limit
viru
replic
abil
cypa
mediat
inflammatori
respons
report
van
de
berg
et
al
cmv
also
mediat
inflammatori
respons
cypa
cmv
stimul
cypa
mediat
activ
pathway
mediat
viral
replic
express
hcmv
promot
activ
mapkerk
pathway
addit
protein
cmv
mediat
viral
gene
express
well
stimul
cellular
express
factor
cjun
junb
creb
histon
acetyltransferas
crebbind
protein
cbp
associ
factor
pcaf
also
play
role
control
gene
activ
factor
mediat
viral
replic
respons
csa
antivir
drug
cyclosporin
immunosuppress
anticmv
drug
resembl
abund
ie
protein
mediat
viru
gene
express
reproduct
abil
overcom
csa
inhibit
cypa
stimul
viral
gene
express
addit
chemokinelik
receptor
protein
interact
hlac
hlag
affect
express
mhc
class
antigen
figur
enabl
virus
evad
immun
respons
cmv
gene
express
occur
sequenc
express
earli
e
gene
occur
first
follow
ie
gene
express
eventu
declin
allow
inhibit
cypa
csa
format
csacypa
complex
complex
inhibit
nfjb
thu
viru
transcript
sinc
earli
e
gene
express
also
cascad
late
l
gene
encod
structur
protein
express
lead
blockag
viru
replic
product
viru
progeni
therefor
csa
may
activ
cmv
replic
function
antivir
drug
inhibit
viru
replic
cypa
vital
hcmv
lytic
infect
latenc
establish
reactiv
protein
serv
target
treatment
hcmv
infect
current
review
describ
anticmv
activ
csa
immunosuppress
drug
commonli
use
organ
transplant
howev
drug
associ
hcmv
reactiv
toxic
immunosuppress
activ
drug
achiev
format
csacypa
complex
suppress
organ
reject
inhibit
calciumcalmodulindepend
calcinerin
protein
major
ie
protein
encod
cmv
ie
gene
mediat
cmv
lytic
cycl
express
depend
protein
cellular
signal
interact
cascad
event
core
determin
whether
csa
activ
suppress
viru
prolifer
sinc
viral
infect
induc
express
inflammatori
cytokin
thrive
immunosuppress
inhibitori
effect
csa
effect
earli
stage
viral
replic
cycl
immun
inflammatori
respons
still
limit
review
previous
publish
data
show
csa
anticmv
activ
use
csa
combin
drug
approv
treatment
cmv
infect
may
also
prevent
develop
unwant
toxic
drug
resist
author
declar
potenti
conflict
interest
respect
research
authorship
andor
public
articl
articl
contain
studi
human
particip
anim
perform
author
